Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463289 · ClinicalTrials.gov registry record · NA
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
A NA study of Type 2 Diabetes and Type 1 Diabetes, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05463289 is a NA study of Type 2 Diabetes and Type 1 Diabetes that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 500 participants, below the 1,101-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05463289, a NA study of Type 2 Diabetes and Type 1 Diabetes, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Point of Care Autonomous AI diabetic retinopathy exam
Study Locations (1)
Maryland
- Johns Hopkins Pediatric Diabetes Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05463289
The ClinicalTrials.gov registry entry for NCT05463289 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,101-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (55% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Point of Care Autonomous AI diabetic retinopathy exam is the first listed.
NCT05463289 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05463289 about?
NCT05463289 is a clinical study titled "ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2". The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the auton...
What is the current status of trial NCT05463289?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2022-07-11. Estimated completion is 2026-03-30.
What conditions does trial NCT05463289 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes, Cystic Fibrosis-related Diabetes.
What interventions are being tested in trial NCT05463289?
The interventions under investigation include: Point of Care Autonomous AI diabetic retinopathy exam (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05463289?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463289 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.